![Harry Stylli](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Harry Stylli
Gründer bei Immunis.AI, Inc.
Aktive Positionen von Harry Stylli
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Duke Institute For Brain Sciences | Direktor/Vorstandsmitglied | - | - |
OncoCell MDx, Inc
![]() OncoCell MDx, Inc BiotechnologyHealth Technology OncoCell MDx, Inc is an American company that focuses on developing and commercializing immunogenic therapies. | Vorsitzender | 01.04.2019 | - |
Immunis.AI, Inc.
![]() Immunis.AI, Inc. Packaged SoftwareTechnology Services Immunis.AI, Inc. develops a non-invasive blood-based immunogenomic platform. The company is based in Royal Oak, MI. The company was founded by Geoffrey R. Erickson, Harry Stylli, Amin I. Kassis. | Vorsitzender | - | - |
Gründer | - | - |
Karriereverlauf von Harry Stylli
Ehemalige bekannte Positionen von Harry Stylli
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BIORA THERAPEUTICS, INC. | Vorstandsvorsitzender | 01.08.2018 | 01.09.2021 |
Vorsitzender | 01.08.2018 | 01.09.2021 | |
Gründer | 01.01.2010 | 01.09.2021 | |
Molecular Insight Pharmaceuticals, Inc.
![]() Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | 01.01.2004 | 12.05.2010 |
SEQUENOM, INC. | Vorstandsvorsitzender | 01.06.2005 | 28.09.2009 |
Präsident | 01.06.2005 | 28.09.2009 | |
XENCOR, INC. | Präsident | 01.11.2004 | 01.02.2005 |
CovX Research LLC
![]() CovX Research LLC BiotechnologyHealth Technology Part of Pfizer Inc., CovX Research LLC is a company that manufactures biotherapeutics and medical products. The company is based in San Diego, CA. The company was founded by Richard Alan Lerner, Carlos F. Barbas. CovX Research was acquired by Pfizer Inc. from Tavistock Life Sciences Co. on January 31, 2008 for $230 million. | Präsident | 01.05.2002 | 01.07.2003 |
Aurora Biosciences Corp.
![]() Aurora Biosciences Corp. BiotechnologyHealth Technology Aurora Biosciences Corp. designs and develops proprietary drug discovery systems, services and technologies to the discovery of new medicine. It develops a proprietary ultra-high throughput screening platform that uniquely integrates innovative fluorescence chemistry, molecular biology, miniaturization, automation, and informatics. The company also provides assay development and screening services. Aurora was founded in 1995 and is located in San Diego, CA. | Präsident | 01.01.1995 | 01.01.2002 |
░░░ ░░░░ ░░░ | ░░░░░░░░░ | - | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Ausbildung von Harry Stylli
University of London | Doctorate Degree |
The Open University | Masters Business Admin |
University of East London | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 11 |
Vereinigtes Königreich | 4 |
Kanada | 2 |
Operativ
President | 5 |
Director/Board Member | 3 |
Chairman | 3 |
Sektoral
Health Technology | 8 |
Consumer Services | 4 |
Health Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
XENCOR, INC. | Health Technology |
BIORA THERAPEUTICS, INC. | Health Services |
Private Unternehmen | 9 |
---|---|
Aurora Biosciences Corp.
![]() Aurora Biosciences Corp. BiotechnologyHealth Technology Aurora Biosciences Corp. designs and develops proprietary drug discovery systems, services and technologies to the discovery of new medicine. It develops a proprietary ultra-high throughput screening platform that uniquely integrates innovative fluorescence chemistry, molecular biology, miniaturization, automation, and informatics. The company also provides assay development and screening services. Aurora was founded in 1995 and is located in San Diego, CA. | Health Technology |
Sequenom, Inc.
![]() Sequenom, Inc. Medical SpecialtiesHealth Technology Sequenom, Inc. engages in the provision of early patient management information. It develops and commercializes molecular diagnostic testing services that serve women's health and oncology markets. The company was founded by Hubert Koester and Charles R. Cantor in October 09, 1996 and is headquartered in Burlington, NC. | Health Technology |
Molecular Insight Pharmaceuticals, Inc.
![]() Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Health Services |
Micropharma Ltd.
![]() Micropharma Ltd. Pharmaceuticals: MajorHealth Technology Micropharma Ltd. formulates, manufactures & sells functional food, neutraceuticals and pharmaceutical products. The company was founded by Satya Prakash in 2002 and is headquartered in North Vancouver, Canada. | Health Technology |
Pan Vera LLC
![]() Pan Vera LLC BiotechnologyHealth Technology PanVera LLC develops protein drug targets and drug screening assays for high throughput screening. The company is headquartered in Madison, WI. | Health Technology |
CovX Research LLC
![]() CovX Research LLC BiotechnologyHealth Technology Part of Pfizer Inc., CovX Research LLC is a company that manufactures biotherapeutics and medical products. The company is based in San Diego, CA. The company was founded by Richard Alan Lerner, Carlos F. Barbas. CovX Research was acquired by Pfizer Inc. from Tavistock Life Sciences Co. on January 31, 2008 for $230 million. | Health Technology |
OncoCell MDx, Inc
![]() OncoCell MDx, Inc BiotechnologyHealth Technology OncoCell MDx, Inc is an American company that focuses on developing and commercializing immunogenic therapies. | Health Technology |
Duke Institute For Brain Sciences | |
Immunis.AI, Inc.
![]() Immunis.AI, Inc. Packaged SoftwareTechnology Services Immunis.AI, Inc. develops a non-invasive blood-based immunogenomic platform. The company is based in Royal Oak, MI. The company was founded by Geoffrey R. Erickson, Harry Stylli, Amin I. Kassis. | Technology Services |
- Börse
- Insiders
- Harry Stylli
- Erfahrung